Pharma News, 2025

Swedish startup secures €2.3M seed funding to boost AI monitoring tools for preclinical research

Merck Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug

UK pharma drug price talks break down as industry fails to lower discount rate

Johnson & Johnson reveals $2 billion update on Fujifilm factory in Holly Springs

“Back in the U.S.A.”: FDA Launches PreCheck Program to Boost Domestic Drug Manufacturing

FDA approves Jazz Pharmaceuticals’ Modeyso as first drug for ultra-rare brain cancer

Santen and RemeGen sign licence deal for retinal disease injection

Lupin launches Bosentan tablets for oral suspension in US market

AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease

The European Commission (EC) has granted marketing authorisation to SpringWorks Therapeutics, a subsidiary of Merck KGaA

HCM CITY — AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its commitment to building a sustainable, people-centred workp...

Sanofi’s Tzield (teplizumab) has become the first immunotherapy to be approved for type 1 diabetes in the UK after being authorised by the Medicines and Healthcare products Regulatory Agency...